Cargando…

Cyclophosphamide for the treatment of Acute Exacerbation of Interstitial Lung Disease: A Review of the Literature

Acute exacerbation of interstitial lung disease is a serious and life-threatening event but little is known about its treatment. Cyclophosphamide has been proposed in randomized clinic trials as a treatment option in progressive cases of systemic sclerosis related interstitial lung disease. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Innabi, Ayoub, Gomez-Manjarres, Diana, Alzghoul, Bashar N., Chizinga, Mwelwa, Mehrad, Borna, Patel, Divya C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050619/ https://www.ncbi.nlm.nih.gov/pubmed/33867789 http://dx.doi.org/10.36141/svdld.v38i1.11271

Ejemplares similares

Macrophage activating syndrome causing decompensated right heart failure
por: Chizinga, Mwelwa, et al.
Publicado: (2021)

A novel technique of needle setting for curvilinear endobronchial ultrasound: Improved efficiency with no cost
por: Meena, Nikhil, et al.
Publicado: (2016)

Rethinking the Doses of Tissue Plasminogen Activator and Deoxyribonuclease Administrated Concurrently for Intrapleural Therapy for Complicated Pleural Effusion and Empyema
por: Innabi, Ayoub, et al.
Publicado: (2018)

Iatrogenic Right-Sided Pneumothorax Presenting as ST-Segment Elevation: A Rare Case Report and Review of Literature
por: Alzghoul, Bashar, et al.
Publicado: (2017)

Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study
por: Alzghoul, Bashar N., et al.
Publicado: (2021)

Central Venous Line Insertion Revealing Partial Anomalous Pulmonary Venous Return: Diagnosis and Management
por: Alzghoul, Bashar, et al.
Publicado: (2017)

Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
por: Odackal, John, et al.
Publicado: (2020)

Diagnostic and therapeutic practices of cardiac sarcoidosis in the United States: A nationwide questionnaire based study
por: Younis, Moustafa, et al.
Publicado: (2023)

A bronchoscopic approach to benign subglottic stenosis
por: Raman, Tuhina, et al.
Publicado: (2017)

Acute Exacerbation in Interstitial Lung Disease
por: Leuschner, Gabriela, et al.
Publicado: (2017)

Acute exacerbation in interstitial lung disease
por: Alhamad, Esam H., et al.
Publicado: (2021)

Pulmonary hypertension in eosinophilic versus noneosinophilic COPD
por: Alzghoul, Bashar N., et al.
Publicado: (2021)

Mesenteric lymphadenitis as a presenting feature of Whipple’s disease
por: Chizinga, Mwelwa, et al.
Publicado: (2017)

Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial
por: Gomez-Manjarres, Diana C., et al.
Publicado: (2023)

COVID-19 and acute exacerbation of interstitial lung disease
por: Kondoh, Yasuhiro, et al.
Publicado: (2021)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2023)

Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases
por: Ito, Yoko, et al.
Publicado: (2019)

Acute exacerbations of interstitial lung disease: what is the best treatment?
por: Meyer, Keith C.
Publicado: (2021)

Acute exacerbation of interstitial lung disease in the intensive care unit
por: Charokopos, Antonios, et al.
Publicado: (2022)

First case of minimal change nephrotic syndrome resolving with antifungal therapy for isolated pleural cryptococcal infection
por: Chizinga, Mwelwa, et al.
Publicado: (2020)

Interstitial pneumonia induced by cyclophosphamide: A case report and review of the literature
por: Qian, Panpan, et al.
Publicado: (2019)

Prevalence of viral infection in acute exacerbation of interstitial lung diseases in Japan
por: On, Rintaro, et al.
Publicado: (2020)

Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease
por: León Román, Francisco, et al.
Publicado: (2023)

Fibrocytes and the pathogenesis of diffuse parenchymal lung disease
por: Mehrad, Borna, et al.
Publicado: (2012)

Cyclophosphamide for interstitial lung disease-associated acute respiratory failure: mortality, clinical response and radiological characteristics
por: van Gemert, Johanna P., et al.
Publicado: (2021)

Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases
por: Nucera, Valeria, et al.
Publicado: (2021)

Acute Exacerbation of Interstitial Lung Disease as a Sequela of COVID-19 Pneumonia
por: Fonseca, Mario, et al.
Publicado: (2021)

Combined ultrasound–CT approach to monitor acute exacerbation of interstitial lung disease
por: Mongodi, Silvia, et al.
Publicado: (2020)

Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

Secondary analysis of preoperative predictors for acute postoperative exacerbation in interstitial lung disease
por: Seto, Fumiko, et al.
Publicado: (2023)

Erratum to acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature
por: Manfredi, Andreina, et al.
Publicado: (2020)

Predictors of postoperative acute exacerbation of interstitial lung disease: a case–control study
por: Hosoki, Keisuke, et al.
Publicado: (2020)

Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases
por: Saraya, Takeshi, et al.
Publicado: (2018)

Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
por: Jang, Hye Jin, et al.
Publicado: (2021)

Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Faverio, Paola, et al.
Publicado: (2021)

Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease
por: Isshiki, Takuma, et al.
Publicado: (2022)

Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination
por: Sakayori, Masashi, et al.
Publicado: (2023)

Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease
por: Salonen, Johanna, et al.
Publicado: (2023)

Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world
por: Kato, Motoyasu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f1u8b12gsukpnv3u6bj8hmlm1j